EULAR updates PRP guidelines: Enhancing patient involvement in rheumatic disease research

FHS
June 18, 2024
6:01 am

In recent years, the benefits of involving PRPs has increasing been recognized. The role is an important one, which goes well beyond the inclusion of patients as study participants.

Dexcom shares plunge on lower sales outlook

By the numbers Q2 revenue: $1 billion 15% increase year-over-year Net income: $143.5 million About 24% increase year-over-year 2024 forecast: Organic sales growth of 11%

July 26, 2024

What clinical real-world data can deliver

Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis

May 22, 2024

Gene editing delivery biotech GenEdit partners with Genentech, raises another $24M

Gene editing still needs better delivery systems, more than half a dozen years after Kunwoo Lee recalls CRISPR pioneer Jennifer Doudna telling attendees at a

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.